Invention Grant
- Patent Title: Derivatives of cephalosporin for treating cancer
-
Application No.: US15301462Application Date: 2015-04-02
-
Publication No.: US10821114B2Publication Date: 2020-11-03
- Inventor: Arnaud Sinan Karaboga , Violeta Isabel Perez-Nueno , Michel Souchet , Didier Decaudin
- Applicant: INSTITUT CURIE , HARMONIC PHARMA
- Applicant Address: FR Paris FR Villers les Nancy
- Assignee: INSTITUT CURIE,HARMONIC PHARMA
- Current Assignee: INSTITUT CURIE,HARMONIC PHARMA
- Current Assignee Address: FR Paris FR Villers les Nancy
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@785ae8d4
- International Application: PCT/EP2015/057310 WO 20150402
- International Announcement: WO2015/150516 WO 20151008
- Main IPC: A61K31/545
- IPC: A61K31/545 ; A61K45/06 ; A61K47/32
Abstract:
The present invention relates to a new class of cephalosporin derivatives of formula (I), notably having CXCR4 receptor antagonist effect, useful as a therapeutic agent for treating cancer, in particular for treating breast cancer, lung cancer and uveal melanoma. The invention further relates to a pharmaceutical composition comprising a compound of formula (I) and an additional antitumor drug for treating cancer.
Public/Granted literature
- US20170119784A1 NEW DERIVATIVES OF CEPHALOSPORIN FOR TREATING CANCER Public/Granted day:2017-05-04
Information query
IPC分类:
